- Feb.1,2022 News release FIMECS Announces Strategic Research Collaboration with Astellas to Discover Protein Degraders Against Multiple Targets 185.45 KB
- Jan.24,2022 News release FIMECS Announces 1,175 Million JPY (ca. 10.3 Million USD) Series B Financing to Advance its Protein Degrader Pipeline and Platform 223.52 KB
- Nov.9,2021 News release FIMECS was Awarded The Global Health Innovative Technology Fund 222.49 KB
- Sep.13,2021 News release FIMECS Organizes Scientific Advisory Board 156.97 KB
- Aug.18,2021 News release FIMECS was Adopted 250M JPY of Grant Funding, “Product Commercialization Alliance (PCA)” 137.08 KB
- Feb.14,2021 News release FIMECS Presents at Virtual Symposium: Targeted Protein Degradation & PROTAC 163.50 KB
- Jan.21,2021 News release FIMECS is Named by The 2020 APAC Business Awards as “Best Tech-Based Drug Discovery Biotech – Japan” 171.14 KB
- Jan.1,2021 News release FIMECS Appoints Dr. Kanae Gamo as Chief Scientific Officer 141.62 KB
- Nov.12,2020 News release Publication about the AID2 technology as a collaboration with National Institute of Genetics 171.14 KB
